RESUMO
The article provides clinical observation of a patient who was diagnosed with celiac disease when he was 52 years (Marsh stage IIIB). Following gluten-free diet (GFD) clinical remission and restoration of small intestinal mucosa (SIM) structure occurred, however in 6 years ulcerative colitis developed and an impairment of SIM morphological structure was identified (Marsh stage IIIA). Ulcerative colitis and celiac disease remission is supported by GFD, anti-cytokine therapy (adalimumab) in combination with mesalazine.
Assuntos
Doença Celíaca/dietoterapia , Colite Ulcerativa/tratamento farmacológico , Dieta Livre de Glúten , Duodeno/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Adalimumab/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Doença Celíaca/imunologia , Colite Ulcerativa/complicações , Duodeno/metabolismo , Humanos , Mucosa Intestinal/metabolismo , Intestino Delgado , Masculino , Mesalamina/uso terapêutico , Resultado do TratamentoRESUMO
The paper presents the All-Russian consensus on the diagnosis and treatment of celiac disease in children and adults, which has been elaborated by leading experts, such as gastroenterologists and pediatricians of Russia on the basis of the existing Russian and international guidelines. The consensus approved at the 42nd Annual Scientific Session of the Central Research Institute of Gastroenterology on Principles of Evidence-Based Medicine into Clinical Practice (March 2-3, 2016). The consensus is intended for practitioners engaged in the management and treatment of patients with celiac disease. Evidence for the main provisions of the consensus was sought in electronic databases. In making recommendations, the main source was the publications included in the Cochrane Library, EMBASE, MEDLINE, and PubMed. The search depth was 10 years. Recommendations in the preliminary version were reviewed by independent experts. Voting was done by the Delphic polling system.
Assuntos
Doença Celíaca , Gerenciamento Clínico , Adulto , Doença Celíaca/classificação , Doença Celíaca/diagnóstico , Doença Celíaca/terapia , Criança , Medicina Baseada em Evidências , Humanos , Federação RussaRESUMO
The paper describes a 56-year-old female patient who in December 2015 lost her appetite and 20 kg of weight, had diarrhea, rapidly increasing weakness, dizziness, joint pains, fever, swelling of the feet, and convulsions. Blood tests revealed anemia, elevated erythrocyte sedimentation rate, and hypoproteinemia. Computed tomography showed enlarged mesenteric and retroperitoneal lymph nodes. The doctor suspected lymphoma and referred her to the Moscow Clinical Research Center. The diagnosis of Whipple's disease was established by carrying out a small intestinal (duodenal) mucosal biopsy with the PAS reaction. A fat-free diet and antibiotic therapy with co-trimoxazole 2.0 g/day and ciprolen 0.3 g/day were prescribed for the patient. Fever and diarrhea disappeared, appetite appeared, weight gained, and blood counts normalized over 1 month of treatment. The patient was discharged with a recommendation to continue antibiotic treatment until the histopathological signs of the disease ceased.
Assuntos
Doença de Whipple/diagnóstico , Antibacterianos/uso terapêutico , Dieta com Restrição de Gorduras , Feminino , Humanos , Pessoa de Meia-Idade , Doença de Whipple/dietoterapia , Doença de Whipple/tratamento farmacológicoRESUMO
The paper describes a clinical case of celiac disease with grade 3 malabsorption, which is associated with recurrent aphthous stomatitis and schizophrenia. On readmission after 8 months of strict adherence to his gluten-free diet, the patient was observed to be in clinical remission and to have normalized laboratory indices and immunological tests. The signs of recurrent stomatitis disappeared. However, the symptoms of the mental disease remained.
Assuntos
Doença Celíaca/dietoterapia , Dieta Livre de Glúten/estatística & dados numéricos , Esquizofrenia/dietoterapia , Estomatite Aftosa/dietoterapia , Adulto , Humanos , Masculino , Recidiva , Resultado do Tratamento , Adulto JovemRESUMO
AIM: To elaborate recommendations for rehabilitation of patients with gluten-sensitivity celiac disease (GCD) on the basis of a long-term follow-up. SUBJECTS AND METHODS: Eighty-seven patients with GCD were followed up for as long as 31 years. Of those, 72.4% of the patients kept strictly to their gluten-free diet (GFD) throughout the follow-up; 9.2% did not follow the diet periodically; and 18.4% did not at all. The sera from 71 patients were tested for IgA and IgG anti-gliadin antibodies (AGAb) and anti-tissue transglutaminase antibodies (ATTGAb) at as long as 19-year follow-up. AGAb and ATTGAb were estimated by enzyme immunoassay (IMMCO Diagnostics). All the patients underwent endoscopic and histological examinations of the small bowel mucosa (SBM). RESULTS: To support the validity of keeping to the GFD, the time course of clinical, laboratory, and morphological changes were analyzed in 63 and 24 GFD followers and non-followers, respectively. The GFD non-followers were more frequently found to have diarrheic syndrome, symptoms of malabsorption syndrome, lower serum concentrations of hemoglobin, total protein, iron, and calcium; no SBM structural recovery was seen in any patient. When the GFD was long adhered to, there was also a reduction in detection rates and AGAb and ATTGAb concentrations. CONCLUSION: The adherence to the GFD was ascertained to contribute to fuller rehabilitation in the patients. However, even the patients who had strictly kept to their GFD showed periods of an exacerbation and incomplete SBM structural recovery. Therefore, the rehabilitation system for patients with GCD must involve diagnostic, therapeutic, and organizational measures that promote not only rapid clinical recovery, but also better quality of life in these patients.
Assuntos
Autoanticorpos/sangue , Doença Celíaca/reabilitação , Dieta Livre de Glúten , Glutens/imunologia , Mucosa Intestinal/imunologia , Adulto , Doença Celíaca/imunologia , Feminino , Seguimentos , Glutens/metabolismo , Humanos , Mucosa Intestinal/patologia , Masculino , Resultado do TratamentoRESUMO
The review considers disturbed metabolism of vitamins, minerals, and protein in patients following bariatric surgery. The positive effect of the surgery is proven; however, postresection syndromes that may further occur determine not only a patient follow-up, but also timely therapeutic interventions to prevent hypovitaminoses, anemia, and mineral metabolic disturbances. There are conflicting data on the incidence of these abnormalities. No guidelines for their treatment and prevention have been elaborated.
Assuntos
Cirurgia Bariátrica/efeitos adversos , Alimentos , Absorção Intestinal/fisiologia , Micronutrientes/metabolismo , Obesidade/cirurgia , Humanos , Obesidade/metabolismoRESUMO
The prevalence of celiac disease is about 1% in the population and is growing due to the wide use of immunological methods of diagnosis. In recent years, in-depth research of the celiac disease has led not only to an increase in the number of patients with celiac disease, but also to the emergence of a broad spectrum of diseases associated with the ingestion of gluten. In this regard, a new pathology, known as "gluten intolerance or gluten sensitivity", attracted special attention of researchers. Studies in recent years have established that patients with this pathology may have both gastrointestinal symptoms and extraintestinal manifestations. Examinations of such patients usually do not find histological changes of the mucous membrane of the small intestine and autoimmune antibodies (to tissue transglutaminase (tTG) and endomysial (EMA)); however an increased level of gliadin antibodies (AGA) is often observed. Allergy to gluten is also absent. A gluten-free diet for such patients, like in case of the celiac disease, leads to the disappearance of clinical symptoms. Exact criteria for the diagnosis of this nosology have not been identified so far, but most researchers believe that prevalence of "gluten intolerance" is much higher than that of celiac disease.
Assuntos
Doença Celíaca , Dieta Livre de Glúten , Glutens/efeitos adversos , Autoanticorpos/sangue , Doença Celíaca/diagnóstico , Doença Celíaca/dietoterapia , Doença Celíaca/patologia , Diagnóstico Diferencial , Gliadina/imunologia , Humanos , Intestino Delgado/imunologia , Intestino Delgado/patologia , Transglutaminases/imunologiaRESUMO
The treatment policy of nutritive support for patients with different types of celiac disease is still actual issue. The difficulty of treatment policy implementation associated with villus atrophy, that brings on not only small intestine malabsorption function, but secretory process disorder (particularly, some of intestinal ferments production, including carbohydrases. The work objective is different types of celiac disease (typical, latent, torpid) nutritive correction improvement based on study of small intestine mucous membrane morphofunctional features at different stages of its atrophy, its carbohydrase activity that identifies clinic manifestation features, including nutritional disorders. We suppose, that such phermentopathy correction by means of directional action composites will have a wholesome effect on elimination of different nutritive disorder at celiac disease.
Assuntos
Doença Celíaca/dietoterapia , Dieta Livre de Glúten , Glicosídeo Hidrolases/deficiência , Mucosa Intestinal/enzimologia , Intestino Delgado/enzimologia , Apoio Nutricional/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Metabolismo dos Carboidratos , Doença Celíaca/enzimologia , Doença Celíaca/patologia , Feminino , Alimentos Formulados , Humanos , Mucosa Intestinal/patologia , Intestino Delgado/patologia , Masculino , Pessoa de Meia-Idade , Estado Nutricional , Índice de Gravidade de Doença , Resultado do Tratamento , Adulto JovemRESUMO
The article presents data of domestic and foreign literature on intestinal dysbacteriosis. It is evident that intestinal dysbiosis always secondary and its correction should take into account the reasons that caused the violation of the microbial composition of the intestinal flora and the clinical manifestations of this syndrome. The characteristic of the normal intestinal microflora and its significance for the human body. It was emphasized that the resident microflora influences the development of the immune response of the intestinal mucosa, epithelial differentiation and proliferation, motility, is actively involved in the digestion and absorption, and synthesis of vitamins and bioactive substances. It was described factors leading to violation of the microbial composition of intestine, as well as methods of diagnosis and treatment of dysbiosis. Therapeutic measures for dysbiosis conducted according to the nature and severity of underlying disease and were in compliance with dietary recommendations and the use of drugs, normalizing the intestinal microflora. In order to remove from the intestinal lumen conditionally pathogenic microorganisms and toxins using different chelators. One of the members of this group of drugs is Laktofiltrum. Laktofiltrum drug effective in treating patients with bowel diseases, accompanied by dysbiosis, as a monotherapy and in combination with other drugs.
Assuntos
Enteropatias/diagnóstico , Mucosa Intestinal/microbiologia , Enteroadsorção , Humanos , Enteropatias/microbiologia , Enteropatias/terapiaRESUMO
UNLABELLED: Violation of reproductive function in patients with celiac disease can manifest as delayed puberty, infertility, amenorrhea, premature menopause, spontaneous abortion, low birth weight. The aim of the study was to establish the frequency and nature of reproductive function violation in patients with CD in the Russian Federation. MATERIALS AND METHODS: The study included 132 women (average age 38,5 +/- 1,17 years) with CD observed in CSRIG in the period from 2000 to 2010. Comparison group consisted 105 women (average age 38,7 +/- 1,6 years) with predominantly functional bowel disorders (irritable bowel syndrome, functional constipation, functional bloating, inert colon). Were took into account information regarding obstetric history, physical and laboratory signs of malabsorption syndrome (MS) study of antibodies to alpha-gliadin immunoglobulin (IG) A class (AGA) and tissue transglutaminase (AtTG). RESULTS: The average age of onset of menses was 14,3 +/- 1,4 years, and in the control group - 13,0 +/- 1,3 years (p > 0.05), half of patients with C (43.9%) had menstruation begun at age 15 years and older, while 7.6% of the women--aged 17 and older. In the comparison group menses beginning after 15 years was only at 13.3% of women. In 61.3% of patients with CD was irregular menstrual cycle while in the comparison group such violations were noted in 13.3% (p < 0.001). Prolonged periods of amenorrhea we observed in women with newly diagnosed GC 3 times more likely than the comparison group: 43.9% and 11.4% respectively (p < 0.01). They also had nearly 3 times more likely to occur spontaneous miscarriage: at 46.9% and 14.3% respectively (p < 0.01). The frequency of dead children birth was about the same: 2.3% and 1.9% respectively (p > 0.05). The frequency of reproductive disorders increased with the growth of the severity of MS. In 43% of women after 6-8 months of strict adherence to a gluten-free diet (GFD) had disappeared amenorrhea and there were regular menses. Three women of childbearing age, strictly abided the GFD and had a history of repeated spontaneous abortion during the year managed to get pregnant and give birth to healthy full-term baby. CONCLUSIONS: Reproductive disorders in women with celiac disease are significantly more likely than at women with functional bowel disease. One of the reasons of reproductive disorders in patients with CD can be malabsorption of necessary nutrients in the small intestine. The presence of reproductive disorders should be considered as a risk factor for celiac disease, so these women should be screened for celiac disease.
Assuntos
Aborto Espontâneo/epidemiologia , Doença Celíaca/dietoterapia , Dieta Livre de Glúten , Infertilidade Feminina/epidemiologia , Distúrbios Menstruais/epidemiologia , Aborto Espontâneo/prevenção & controle , Adolescente , Adulto , Idoso , Estudos de Casos e Controles , Doença Celíaca/epidemiologia , Doença Celíaca/etiologia , Feminino , Humanos , Infertilidade Feminina/complicações , Infertilidade Feminina/prevenção & controle , Distúrbios Menstruais/complicações , Distúrbios Menstruais/prevenção & controle , Pessoa de Meia-Idade , Reprodução/fisiologia , Fatores de Risco , Índice de Gravidade de Doença , Natimorto/epidemiologia , Adulto JovemRESUMO
The study examined the genetic predisposition to the development of glutensensitive celiac disease (CD). Were analyzed samples of peripheral blood of 17 adult patients diagnosed with CD, as well as samples of umbilical cord blood of 1700 newborns of healthy children. HLA-typing was performed using two basic methods of molecular typing--SSO and SSP. The studies revealed the specificity of HLA-B*08; HLA-DRB1*2003; HLA-DRB1*07 and HLA-DQB1*02, which are the genetic markers of CD. Was identified a combination of HLA-markers of CD, each of which is a genetic marker for CD: HLA-B*08; HLA-DRB1*2003; HLA-DQB1*02 and HLA-DRB1*2007; HLA-DQB1*02/HLADQB1*03. In addition, negative associations were identified with CD specificity of HLA-DQB1*05. Thus, the results indicate the possibility of individual risk predicting of CD developing in a healthy population and in families of patients with CD.
Assuntos
Doença Celíaca/genética , Doença Celíaca/imunologia , Predisposição Genética para Doença , Antígenos HLA/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Doença Celíaca/sangue , Doença Celíaca/epidemiologia , Sangue Fetal/imunologia , Frequência do Gene , Predisposição Genética para Doença/epidemiologia , Genótipo , Humanos , Recém-Nascido , Pessoa de Meia-Idade , Moscou/epidemiologia , Adulto JovemRESUMO
We described a patient 40 years old, admitted to the clinic with periodic attacks of pain in the right upper quadrant. With ultrasound it was confirmed chronic acalculous cholecystitis, and at endoscopy and multiple biopsies revealed atrophy of the mucosa of the duodenum (DM), corresponding to celiac disease (stage III in the Marsh classification). Titer of antibodies to gliadin (AGA) and tissue transglutaminase (AtTG) were higher: 60 and 110 units/ml, respectively, at a rate of 10 units/ml. The patient was assigned a lifetime adherence to a gluten-free diet, serologic test and a control endoscopy with biopsy at 6 months. The important role of the doctor-endoscopist in the diagnosis of latent forms of celiac disease. The significance of DM atrophy in the pathogenesis of patients with chronic cholecystitis.
Assuntos
Colecistite Acalculosa/diagnóstico , Doença Celíaca/diagnóstico , Colecistite Acalculosa/complicações , Colecistite Acalculosa/tratamento farmacológico , Adulto , Doença Celíaca/complicações , Doença Celíaca/dietoterapia , Dieta Livre de Glúten , Feminino , Humanos , Resultado do TratamentoRESUMO
In this article presented results of examination and treatment of 207 patients with glutensensitive celiac disease. And also you can find comprehensive method for the treatment of patients with varying severity of disease. The fundamental method of therapy glutensensitive celiac disease is strict lifelong adherence to a gluten-free diet (GFD), which eliminated protein cereal--gluten contained in wheat, rye and barley. Recently, there is large number of products which include the "hidden gluten". Its elimination from the diet of GFD is mandatory for patients with celiac disease. In the presence of diarrhea and malabsorption syndrome are used adsorbents, astringents, enzymes, intestinal antiseptic, probiotics. With the purpose of correction of metabolic disorders intravenous electrolyte mixture containing potassium, calcium and magnesium. To eliminate protein deficiency drugs used solid protein mixture of pure amino acids, gluten-free mixes for enteral feeding. Clinical examination of patients with celiac disease is aimed at monitoring compliance with GFD, early detection of cancer, autoimmune and other related diseases.
Assuntos
Doença Celíaca/prevenção & controle , Dieta Livre de Glúten , Glutens/efeitos adversos , Adolescente , Adulto , Amilases/metabolismo , Doença Celíaca/diagnóstico , Doença Celíaca/tratamento farmacológico , Doença Celíaca/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes de Função Pancreática , Índice de Gravidade de Doença , Resultado do Tratamento , Adulto JovemRESUMO
AIM: To study condition of the stomach, gall-bladder, pancreas, liver in celiac disease (CD) and contribution of their dysfunction to clinical presentation of CD symptoms. MATERIAL AND METHODS: A total of 215 CD patients entered the study (191 females and 24 males) aged under 20 years (n=100), 20 to 50 (n=74) and over 50 years (n=41). The control group consisted of 25 healthy volunteers. Acid-forming function of the stomach, blood serum gastrin level were studied. Bile for biochemical test was obtained at duodenal intubation using 40 ml of 40% glucose solution or 25% magnesium solution as food stimulators, and intravenous injection of cholecystokininpancreosimin. Cholic acid was assayed in bile portions B and C. Two-channel probe was used to obtain duodenal content before meal and after intravenous injection of pancreosimin for tripsin, amylase and lipase assay. Clinical and biochemical blood tests were made as well as puncture biopsy of the liver with histological study of biopsy material. RESULTS: CD patients were found to have high basal and stimulated acid-forming function, high gastrin concentration in the blood. The morphological examination detected lymphocytic gastritis. There were an inert type of pancreatic enzyme secretion, gall-bladder hypokinesia or atony. Gall-bladder contracted only after intravenous injection of cholecystokinin. Changes in the liver were characterized by hypertransaminasemia, steatohepatitis. CONCLUSION: Changes in the stomach in patients with new-onset CD promote formation of ulcer. Decline in excretory pancreatic function, slow enzyme secretion, marked hypokinesia of the gall-bladder, hyperenzymemia and steatohepatitis as manifestations of hepatic pathology result in dramatic disorder of digestion and absorption of food substances.
Assuntos
Biomarcadores/metabolismo , Doença Celíaca/metabolismo , Vesícula Biliar/metabolismo , Mucosa Gástrica/metabolismo , Fígado/metabolismo , Pâncreas/metabolismo , Adolescente , Adulto , Idoso , Amilases/sangue , Bile/metabolismo , Feminino , Gastrinas/sangue , Humanos , Lipase/sangue , Masculino , Pessoa de Meia-Idade , Prognóstico , Tripsina/sangue , Adulto JovemRESUMO
Gluten-sensitive enteropathy (Celiac Disease)--is an autoimmune inflammatory disease, with hyper Regenerative atrophy of the mucous membrane of the small intestine, that is precipitated by the ingestion of gluten, a component of wheat rye, barley, protein. Exclusion of dietary gluten results in healing of the mucosa of the small intestine. The main method of treatment and prevention of complications of celiac disease is strict lifelong adherence to gluten-free diet (AGD), which reduces the quality of life of patients. The labeling of all foods and greater variety of gluten-free products, reducing their cost, psychological support doctors and nutritionists will improve their quality of life.
Assuntos
Doenças Autoimunes/economia , Doença Celíaca/economia , Dieta Livre de Glúten/economia , Dieta Livre de Glúten/métodos , Rotulagem de Alimentos , Glutens , Doenças Autoimunes/epidemiologia , Doenças Autoimunes/terapia , Doença Celíaca/epidemiologia , Doença Celíaca/terapia , Humanos , Federação Russa/epidemiologiaRESUMO
The incidence of celiac disease in the elderly patients in recent years is increasing and is 7.2% of all examinees. More than half of patients with onset of the disease is characterized by severe malabsorption syndrome III degree and is diagnosed in a short time from the first signs of illness. The rest of celiac disease occurs in small symptom long form, so that the diagnosis was first established over 10 years and over from the beginning of the disease. Late diagnosis of celiac disease in the elderly patients, and hence non-gluten-free diet increases the risk of complications such as cancer.
Assuntos
Envelhecimento , Doença Celíaca/diagnóstico , Doença Celíaca/terapia , Adolescente , Adulto , Fatores Etários , Idoso , Doença Celíaca/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/diagnóstico , Neoplasias/etiologia , Neoplasias/terapiaRESUMO
AIM: To examine content, diagnostic and prognostic role of autologous antibodies in gastrointestinal diseases (GID). MATERIAL AND METHODS: Enzyme immunoassay was used to measure content of autologous antibodies to N+/K+ ATPase (Aab) of gastric parietal cells, mitochondria, microsomes, tissue transglutaminase in blood serum of 196 patients with gastric, gallbladder, small and large intestinal diseases. Aab relations with heterologous antibodies were studied with kits provided by Bektor-Best (Novosibirsk), DRG-Diagnostics, Orgentec (Germany) and others. RESULTS: In GID high circulation of Aab to parietal cells (Ab-PC) was detected in 42% cases, mean content being 217 +/- 32.4 U/ml, 10 U/ml in the control. Maximal concentration (180 = 340 U/ml) occurred in hepatic cirrhosis, celiac disease, atrophic gastritis. In exacerbations of pancreatitis, colelithiasis and duodenal ulcer ab-PC concentration was 190-210 U/ml, in remission--6-12 U/ml. Minimal concentration (8-38 U/ml) was seen in polyps, gastric cancer, nonspecific ulcerative colitis. For primary biliary cirrhosis more typical was high A/ab concentration to mitochondria (in 83%; 200 U.ml), for autoimmune hepatitis--Aab to microsomes (in 81%; 170 U/ml), in celial disease--Aab to tissue transglutaminase (93%, 75 U/ml). High autoantibodies concentration in GID is accompanied with overcirculation of heteroantibodies to infectious-toxic agents confirming their role in development of autoimmune processes. CONCLUSION: GID are associated with high circulation of autologous antibodies--markers of systemic humoral autoimmune reactions differing in duration, severity, site of lesion, form, stage, disease duration. Maximal detection rate and concentration of serum autologous antibodies were observed in hepatic cirrhosis, active hepatitis, celiac disease, atrophic gastritis, exacerbations of cholelithiasis, ulcer, pancreatitis. Estimation of Aab concentration is essential for diagnosis, prognosis of autoimmune diseases, it reflects intensity and duration of autoimmune reactions in GID.
Assuntos
Formação de Anticorpos/imunologia , Autoanticorpos/sangue , Autoimunidade , Doenças do Sistema Digestório/imunologia , Biomarcadores/sangue , Humanos , Células Parietais Gástricas/imunologiaRESUMO
It is established that a heightened nitrogen balance is defined by a dysabsorbtion syndrom. Proved that the optimal quota of protein at albuminous insufficiency is about 135 g/day. Parenteral introduction of aminoacidic mixes (Infesol) led to clinical improvement, normalization of an aminoacidic spectrum of blood. Use of mixes for an enteral nutrition (Nutridrink) provides a reduction of symptoms of albuminous deficiency.
Assuntos
Aminoácidos/administração & dosagem , Aminoácidos/sangue , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/terapia , Nutrição Enteral/métodos , Feminino , Humanos , Infusões Parenterais/métodos , Masculino , Deficiência de Proteína/sangue , Deficiência de Proteína/terapiaRESUMO
High concentration of Ab Gl, Ab tTG, Ab Em and Ab Rt and increased amount of immunocompetent cells in the SIM in coeliac disease is an index of the developing specific immune response to gliadin and tissue antigens. High specificity and sensitivity of Ab tTG and Ab Em were determined in celiac disease.